{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:30:12Z","timestamp":1776403812804,"version":"3.51.2"},"reference-count":18,"publisher":"Frontiers Media SA","issue":"10","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/tri.12999","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T09:26:39Z","timestamp":1497345999000},"page":"1041-1050","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study"],"prefix":"10.3389","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1239-5746","authenticated-orcid":false,"given":"Magdalena","family":"Salcedo","sequence":"first","affiliation":[{"name":"Liver Transplant Unit and Digestive Disease Department; IISGM; CIBERehd; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Universidad Complutense; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Prieto","sequence":"additional","affiliation":[{"name":"Liver Unit; Gastroenterology Department; CIBERehd; Hospital Universitari i Polit\u00e8cnic La Fe; Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Castells","sequence":"additional","affiliation":[{"name":"Liver Unit; Internal Medicine Department; CIBERehd; Hospital General Vall d\u2032Hebron; Universitat Aut\u00f2noma de Barcelona; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Pascasio","sequence":"additional","affiliation":[{"name":"UGC Digestive Diseases; CIBERehd; Hospital Universitario Virgen del Roc\u00edo; Sevilla Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Montero Alvarez","sequence":"additional","affiliation":[{"name":"Hepatology Unit; Hospital Universitario Reina Sof\u00eda; C\u00f3rdoba Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Digestive Disease Service; Hospital Universitario 12 de Octubre; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"S\u00e1nchez-Antol\u00edn","sequence":"additional","affiliation":[{"name":"Liver Unit, Liver Transplantation Unit; Hospital Universitario Rio Hortega; Valladolid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Gonz\u00e1lez-Di\u00e9guez","sequence":"additional","affiliation":[{"name":"Liver Unit; Hospital Universitario Central de Asturias; Oviedo Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Garc\u00eda-Gonzalez","sequence":"additional","affiliation":[{"name":"Digestive Diseases Department; Hospital Ram\u00f3n y Cajal; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Otero","sequence":"additional","affiliation":[{"name":"Liver Unit; Hospital Universitario de A Coru\u00f1a; A Coru\u00f1a Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lorente","sequence":"additional","affiliation":[{"name":"Digestive Diseases Department; Hospital Cl\u00ednico Lozano Blesa de Zaragoza; IIS Arag\u00f3n; Zaragoza Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Dolores","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Liver Unit; UGC Digestive Diseases; Complejo Hospitalario Universitario de Granada; Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milagros","family":"Testillano","sequence":"additional","affiliation":[{"name":"Liver Unit and Liver transplantation; Hospital Universitario de Cruces; Bilbao Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Liver Unit; Hospital Universitario Ntra. Sra. de Candelaria; Tenerife Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Castellote","sequence":"additional","affiliation":[{"name":"Digestive Disease Department; IDIBELL; Hospital Universitari de Bellvitge; Universidad de Barcelona; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Casafont","sequence":"additional","affiliation":[{"name":"Gastroenterology Department; Hospital Universitario Marqu\u00e9s de Valdecilla; Santander Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Carlota","family":"Londo\u00f1o","sequence":"additional","affiliation":[{"name":"Liver Unit; CIBERehd; Hospital Cl\u00ecnic Barcelona; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"Pons","sequence":"additional","affiliation":[{"name":"Liver Unit; Hospital Cl\u00ednico Universitario Virgen de la Arrixaca; Murcia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Molina P\u00e9rez","sequence":"additional","affiliation":[{"name":"Abdominal Transplants Unit; Hospital Cl\u00ednico Universitario de Santiago de Compostela; Santiago de Compostela Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valent\u00edn","family":"Cuervas-Mons","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit; Department of Medicine; Hospital Universitario Puerta de Hierro-Majadahonda; Universidad Aut\u00f3noma de Madrid; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Pascual","sequence":"additional","affiliation":[{"name":"Liver Unit; Gastroenterology Department; CIBERehd; Hospital General Universitario de Alicante; Alicante Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Ignacio","family":"Herrero","sequence":"additional","affiliation":[{"name":"Liver Unit; Instituto de Investigaci\u00f3n Sanitaria de Navarra (IdiSNA); CIBERehd; Cl\u00ednica Universidad de Navarra; Pamplona Navarra Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidoro","family":"Narv\u00e1ez","sequence":"additional","affiliation":[{"name":"Liver Transplantation Unit; Gastroenterology Department; Complejo Hospitalario Universitario de Badajoz, \u201cInfanta Cristina\u201d; Badajoz Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Vinaixa","sequence":"additional","affiliation":[{"name":"Gastroenterology Department; CIBERehd; Hospital Universitari i Polit\u00e8cnic La Fe; Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Llaneras","sequence":"additional","affiliation":[{"name":"Liver Unit; Internal Medicine Department; Hospital General Vall Hebr\u00f3n; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Sousa","sequence":"additional","affiliation":[{"name":"UGC Unit; Digestive Diseases; Hospital Universitario Virgen del Roc\u00edo; Sevilla Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit and Digestive Disease Department; Facultad de Medicina Universidad Complutense; IISGM; CIBERehd; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"10.1111\/tri.12999-BIB0001|tri12999-cit-0001","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jhep.2000.17924","article-title":"Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation","volume":"32","author":"Berenguer","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/tri.12999-BIB0002|tri12999-cit-0002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12999-BIB0003|tri12999-cit-0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience","volume":"60","author":"Coilly","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12999-BIB0004|tri12999-cit-0004","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40265-015-0362-5","article-title":"Daclatasvir: a review of its use in adult patients with chronic hepatitis C virus infection","volume":"75","author":"McCormack","year":"2015","journal-title":"Drugs"},{"key":"10.1111\/tri.12999-BIB0005|tri12999-cit-0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0034-1371084","article-title":"Case report of successful treatment of fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin after liver transplantation","volume":"34","author":"Kim","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1111\/tri.12999-BIB0006|tri12999-cit-0006","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.cgh.2015.05.030","article-title":"Efficacy of sofosbuvir and daclatasvir in patients with fibrosing cholestatic hepatitis C after liver transplantation","volume":"13","author":"Leroy","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/tri.12999-BIB0007|tri12999-cit-0007","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/lt.24416","article-title":"Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection","volume":"22","author":"Fontana","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.12999-BIB0008|tri12999-cit-0008","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2016.05.039","article-title":"Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - the ANRS CUPILT study","volume":"65","author":"Coilly","year":"2016","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12999-BIB0009|tri12999-cit-0009","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","article-title":"Daclatasvir with sofosbuvir and ribavirin for HCV infection with advanced cirrhosis or post-liver transplant recurrence","volume":"63","author":"Poordad","year":"2016","journal-title":"Hepatology"},{"key":"10.1111\/tri.12999-BIB0010|tri12999-cit-0010","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"Van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/tri.12999-BIB0011|tri12999-cit-0011","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/lt.23559","article-title":"Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis","volume":"19","author":"Verna","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.12999-BIB0012|tri12999-cit-0012","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(16)00052-9","article-title":"Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial","volume":"16","author":"Manns","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/tri.12999-BIB0013|tri12999-cit-0013","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/tri.12999-BIB0014|tri12999-cit-0014","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/apt.13343","article-title":"Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies","volume":"42","author":"Deterding","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/tri.12999-BIB0015|tri12999-cit-0015","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cgh.2015.04.013","article-title":"Association between severe portal hypertension and risk of liver decompensation in patients with Hepatitis C, regardless of response to antiviral therapy","volume":"13","author":"Lens","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/tri.12999-BIB0016|tri12999-cit-0016","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/TP.0000000000001633","article-title":"Disease reversibility in patients with posthepatitis c cirrhosis: is the point of no return the same before and after liver transplantation? A review","volume":"101","author":"Vinaixa","year":"2017","journal-title":"Transplantation"},{"key":"10.1111\/tri.12999-BIB0017|tri12999-cit-0017","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1016\/S0168-8278(15)30011-8","article-title":"On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation (OLT): interim data from the phase II SATURN study","volume":"62","author":"Forns","year":"2015","journal-title":"J Hepatol"},{"key":"10.1111\/tri.12999-BIB0018|tri12999-cit-0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/tri.12910","article-title":"Real-world experience with daclatasvir plus sofosbuvir \u00b1 ribavirin for post-liver transplant HCV recurrence and severe liver disease","volume":"30","author":"Herzer","year":"2017","journal-title":"Transpl Int"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12999\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:40:11Z","timestamp":1641062411000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12999","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}